| 1 | [SID124753546] | Active | IC50 | 1.05 | Dose response confirmation of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a FRET assay [AID651693, Type: confirmatory] | SENP1 gene product [Homo sapiens] [gi:7657550] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Active | | IC50 | 1.05 [uM] | | BioAssay | Dose response confirmation of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a FRET assay | | AID | 651693 | | BioAssay type | confirmatory | | Target | SENP1 gene product [Homo sapiens] [gi:7657550] | | PubMed | | | Data Table |  |
|
| 2 | [SID124753546] | Active | IC50 | 2.21 | Dose response confirmation of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a kinetic FRET assay [AID651697, Type: confirmatory] | SENP1 gene product [Homo sapiens] [gi:7657550] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Active | | IC50 | 2.21 [uM] | | BioAssay | Dose response confirmation of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a kinetic FRET assay | | AID | 651697 | | BioAssay type | confirmatory | | Target | SENP1 gene product [Homo sapiens] [gi:7657550] | | PubMed | | | Data Table |  |
|
| 3 | [SID124753546] | Active | Potency | 3.6626 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Active | | Potency | 3.6626 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 4 | [SID124753546] | Active | Potency | 5.1735 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Active | | Potency | 5.1735 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 5 | [SID124753546] | Active | Potency | 16.3601 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line [AID686971, Type: confirmatory] | |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Active | | Potency | 16.3601 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line | | AID | 686971 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 6 | [SID124753546] | Active | | | Single concentration confirmation of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a FRET assay [AID651678, Type: screening] | SENP1 gene product [Homo sapiens] [gi:7657550] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Active | | BioAssay | Single concentration confirmation of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a FRET assay | | AID | 651678 | | BioAssay type | screening | | Target | SENP1 gene product [Homo sapiens] [gi:7657550] | | PubMed | | | Data Table |  |
|
| 7 | [SID124753546] | Active | | | Single concentration confirmation of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a kinetic FRET assay [AID651690, Type: screening] | SENP1 gene product [Homo sapiens] [gi:7657550] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Active | | BioAssay | Single concentration confirmation of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a kinetic FRET assay | | AID | 651690 | | BioAssay type | screening | | Target | SENP1 gene product [Homo sapiens] [gi:7657550] | | PubMed | | | Data Table |  |
|
| 8 | [SID124753546] | Active | | | uHTS identification of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a FRET assay [AID624204, Type: screening] | SENP1 gene product [Homo sapiens] [gi:7657550] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Active | | BioAssay | uHTS identification of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a FRET assay | | AID | 624204 | | BioAssay type | screening | | Target | SENP1 gene product [Homo sapiens] [gi:7657550] | | PubMed | | | Data Table |  |
|
| 9 | [SID124753546] | Active | | | qHTS of D3 Dopamine Receptor Antagonist: qHTS [AID652054, Type: screening] | |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Antagonist: qHTS | | AID | 652054 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 10 | [SID124753546] | Active | | | HTS to identify compounds that promote myeloid differentiation with MLPCN compound set [AID624256, Type: screening] | |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Active | | BioAssay | HTS to identify compounds that promote myeloid differentiation with MLPCN compound set | | AID | 624256 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 11 | [SID124753546] | Active | | | Counterscreen for inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS): Luminescence-based cell-based high throughput assay to identify compounds that are cytotoxic to Jurkat human T lymphocyte cells [AID624413, Type: screening] | |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS): Luminescence-based cell-based high throughput assay to identify compounds that are cytotoxic to Jurkat human T lymphocyte cells | | AID | 624413 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 12 | [SID124753546] | Active | | | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify nonselective inhibitors of the Steroidogenic acute regulatory protein (StAR) promoter or luminescence assay artifacts [AID651611, Type: screening] | |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Active | | BioAssay | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify nonselective inhibitors of the Steroidogenic acute regulatory protein (StAR) promoter or luminescence assay artifacts | | AID | 651611 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 13 | [SID124753546] | Active | | | Fluorescence-based biochemical high throughput screening primary assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate [AID651958, Type: screening] | putative polyprotein [Crimean-Congo hemorrhagic fever virus] [gi:76364066] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical high throughput screening primary assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate | | AID | 651958 | | BioAssay type | screening | | Target | putative polyprotein [Crimean-Congo hemorrhagic fever virus] [gi:76364066] | | PubMed | | | Data Table |  |
|
| 14 | [SID124753546] | Active | | | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) [AID651614, Type: screening] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Active | | BioAssay | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) | | AID | 651614 | | BioAssay type | screening | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 15 | [SID124753546] | Active | | | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) [AID651614, Type: screening] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Active | | BioAssay | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) | | AID | 651614 | | BioAssay type | screening | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 16 | [SID124753546] | Active | | | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) [AID651614, Type: screening] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Active | | BioAssay | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) | | AID | 651614 | | BioAssay type | screening | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 17 | [SID124753546] | Active | | | Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS) [AID624268, Type: screening] | methionyl-tRNA synthetase [Trypanosoma brucei brucei strain 927/4 GUTat10.1] [gi:71746704] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Active | | BioAssay | Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS) | | AID | 624268 | | BioAssay type | screening | | Target | methionyl-tRNA synthetase [Trypanosoma brucei brucei strain 927/4 GUTat10.1] [gi:71746704] | | PubMed | | | Data Table |  |
|
| 18 | [SID124753546] | Active | | | Luminescence-based biochemical high throughput confirmation assay for inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS) [AID624412, Type: screening] | methionyl-tRNA synthetase [Trypanosoma brucei brucei strain 927/4 GUTat10.1] [gi:71746704] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Active | | BioAssay | Luminescence-based biochemical high throughput confirmation assay for inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS) | | AID | 624412 | | BioAssay type | screening | | Target | methionyl-tRNA synthetase [Trypanosoma brucei brucei strain 927/4 GUTat10.1] [gi:71746704] | | PubMed | | | Data Table |  |
|
| 19 | [SID124753546] | Active | | | Fluorescent Polarization-based biochemical high throughput orthogonal assay for inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS) [AID651607, Type: screening] | methionyl-tRNA synthetase [Trypanosoma brucei brucei strain 927/4 GUTat10.1] [gi:71746704] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Active | | BioAssay | Fluorescent Polarization-based biochemical high throughput orthogonal assay for inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS) | | AID | 651607 | | BioAssay type | screening | | Target | methionyl-tRNA synthetase [Trypanosoma brucei brucei strain 927/4 GUTat10.1] [gi:71746704] | | PubMed | | | Data Table |  |
|
| 20 | [SID124753546] | Inactive | | | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set [AID588499, Type: Literature] | botulinum neurotoxin type A [Clostridium botulinum A str. ATCC 3502] [gi:148378801] |   View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Inactive | | BioAssay | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | | AID | 588499 | | BioAssay type | Literature | | Target | botulinum neurotoxin type A [Clostridium botulinum A str. ATCC 3502] [gi:148378801] | | PubMed | 16604538 | | Data Table |  |
|
| 21 | [SID124753546] | Inactive | Potency | | qHTS of Trypanosoma Brucei Inhibitors [AID624173, Type: confirmatory] | hypothetical protein, conserved [Trypanosoma brucei] [gi:62359610] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of Trypanosoma Brucei Inhibitors | | AID | 624173 | | BioAssay type | confirmatory | | Target | hypothetical protein, conserved [Trypanosoma brucei] [gi:62359610] | | PubMed | | | Data Table |  |
|
| 22 | [SID124753546] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite H. contortus (hcDAF-12) [AID652067, Type: screening] | Protein DAF-12, isoform a [Caenorhabditis elegans] [gi:71987181] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite H. contortus (hcDAF-12) | | AID | 652067 | | BioAssay type | screening | | Target | Protein DAF-12, isoform a [Caenorhabditis elegans] [gi:71987181] | | PubMed | | | Data Table |  |
|
| 23 | [SID124753546] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite S. stercoralis (ssDAF-12) [AID652126, Type: screening] | Protein DAF-12, isoform a [Caenorhabditis elegans] [gi:71987181] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite S. stercoralis (ssDAF-12) | | AID | 652126 | | BioAssay type | screening | | Target | Protein DAF-12, isoform a [Caenorhabditis elegans] [gi:71987181] | | PubMed | | | Data Table |  |
|
| 24 | [SID124753546] | Inactive | Potency | | qHTS of GLP-1 Receptor Agonists [AID624172, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of GLP-1 Receptor Agonists | | AID | 624172 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 25 | [SID124753546] | Inactive | Potency | | qHTS of GLP-1 Receptor Agonists [AID624172, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of GLP-1 Receptor Agonists | | AID | 624172 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 26 | [SID124753546] | Inactive | Potency | | qHTS for Inhibitors of Glutaminase (GLS) [AID624170, Type: confirmatory] | GLS protein [Homo sapiens] [gi:71051501] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Glutaminase (GLS) | | AID | 624170 | | BioAssay type | confirmatory | | Target | GLS protein [Homo sapiens] [gi:71051501] | | PubMed | | | Data Table |  |
|
| 27 | [SID124753546] | Inactive | | | Inhibition of the MLL-AF4-AF9 Interaction in Pediatric Leukemia Measured in Biochemical System Using Plate Reader - 2160-01_Inhibitor_SinglePoint_HTS_Activity [AID651704, Type: screening] | MLLT3 gene product [Homo sapiens] [gi:156104889] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Inactive | | BioAssay | Inhibition of the MLL-AF4-AF9 Interaction in Pediatric Leukemia Measured in Biochemical System Using Plate Reader - 2160-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 651704 | | BioAssay type | screening | | Target | MLLT3 gene product [Homo sapiens] [gi:156104889] | | PubMed | | | Data Table |  |
|
| 28 | [SID124753546] | Inactive | | | uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay [AID651647, Type: screening] | MMP14 gene product [Homo sapiens] [gi:4826834] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Inactive | | BioAssay | uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay | | AID | 651647 | | BioAssay type | screening | | Target | MMP14 gene product [Homo sapiens] [gi:4826834] | | PubMed | | | Data Table |  |
|
| 29 | [SID124753546] | Inactive | | | uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay [AID651647, Type: screening] | MMP14 gene product [Homo sapiens] [gi:4826834] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Inactive | | BioAssay | uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay | | AID | 651647 | | BioAssay type | screening | | Target | MMP14 gene product [Homo sapiens] [gi:4826834] | | PubMed | | | Data Table |  |
|
| 30 | [SID124753546] | Inactive | | | uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay [AID651647, Type: screening] | MMP14 gene product [Homo sapiens] [gi:4826834] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Inactive | | BioAssay | uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay | | AID | 651647 | | BioAssay type | screening | | Target | MMP14 gene product [Homo sapiens] [gi:4826834] | | PubMed | | | Data Table |  |
|
| 31 | [SID124753546] | Inactive | Potency | | qHTS of Nrf2 Activators [AID624171, Type: confirmatory] | Nrf2 [Homo sapiens] [gi:693842] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of Nrf2 Activators | | AID | 624171 | | BioAssay type | confirmatory | | Target | Nrf2 [Homo sapiens] [gi:693842] | | PubMed | | | Data Table |  |
|
| 32 | [SID124753546] | Inactive | Potency | | qHTS of Nrf2 Activators [AID624171, Type: confirmatory] | Nrf2 [Homo sapiens] [gi:693842] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of Nrf2 Activators | | AID | 624171 | | BioAssay type | confirmatory | | Target | Nrf2 [Homo sapiens] [gi:693842] | | PubMed | | | Data Table |  |
|
| 33 | [SID124753546] | Inactive | Potency | | qHTS of Nrf2 Activators [AID624171, Type: confirmatory] | Nrf2 [Homo sapiens] [gi:693842] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of Nrf2 Activators | | AID | 624171 | | BioAssay type | confirmatory | | Target | Nrf2 [Homo sapiens] [gi:693842] | | PubMed | | | Data Table |  |
|
| 34 | [SID124753546] | Inactive | Potency | | qHTS of Nrf2 Activators [AID624171, Type: confirmatory] | Nrf2 [Homo sapiens] [gi:693842] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of Nrf2 Activators | | AID | 624171 | | BioAssay type | confirmatory | | Target | Nrf2 [Homo sapiens] [gi:693842] | | PubMed | | | Data Table |  |
|
| 35 | [SID124753546] | Inactive | Potency | | A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression [AID624263, Type: confirmatory] | Parkin [Homo sapiens] [gi:3063388] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression | | AID | 624263 | | BioAssay type | confirmatory | | Target | Parkin [Homo sapiens] [gi:3063388] | | PubMed | | | Data Table |  |
|
| 36 | [SID124753546] | Inactive | | | FRET-based HTS for detection of RAD52 Inhibitors Measured in Biochemical System Using Plate Reader - 7018-01_Inhibitor_SinglePoint_HTS_Activity_Set2 [AID651710, Type: screening] | RAD52 gene product [Homo sapiens] [gi:109637798] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Inactive | | BioAssay | FRET-based HTS for detection of RAD52 Inhibitors Measured in Biochemical System Using Plate Reader - 7018-01_Inhibitor_SinglePoint_HTS_Activity_Set2 | | AID | 651710 | | BioAssay type | screening | | Target | RAD52 gene product [Homo sapiens] [gi:109637798] | | PubMed | | | Data Table |  |
|
| 37 | [SID124753546] | Inactive | | | qHTS Assay for Inhibitors of the CtBP/E1A Interaction [AID651724, Type: screening] | CtBP interacting protein CtIP [Homo sapiens] [gi:1730321] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Inactive | | BioAssay | qHTS Assay for Inhibitors of the CtBP/E1A Interaction | | AID | 651724 | | BioAssay type | screening | | Target | CtBP interacting protein CtIP [Homo sapiens] [gi:1730321] | | PubMed | | | Data Table |  |
|
| 38 | [SID124753546] | Inactive | | | Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe [AID651800, Type: screening] | TCRAV4S1 [Homo sapiens] [gi:2358024] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Inactive | | BioAssay | Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe | | AID | 651800 | | BioAssay type | screening | | Target | TCRAV4S1 [Homo sapiens] [gi:2358024] | | PubMed | | | Data Table |  |
|
| 39 | [SID124753546] | Inactive | | | uHTS identification of SUMO1-mediated protein-protein interactions [AID602429, Type: screening] | SUMO-1 [Homo sapiens] [gi:1762973] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Inactive | | BioAssay | uHTS identification of SUMO1-mediated protein-protein interactions | | AID | 602429 | | BioAssay type | screening | | Target | SUMO-1 [Homo sapiens] [gi:1762973] | | PubMed | | | Data Table |  |
|
| 40 | [SID124753546] | Inactive | Potency | | qHTS for Inhibitors of WRN Helicase [AID651768, Type: confirmatory] | WRN [Homo sapiens] [gi:3719421] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of WRN Helicase | | AID | 651768 | | BioAssay type | confirmatory | | Target | WRN [Homo sapiens] [gi:3719421] | | PubMed | | | Data Table |  |
|
| 41 | [SID124753546] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3) [AID651719, Type: screening] | GALR3 gene product [Homo sapiens] [gi:4503907] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3) | | AID | 651719 | | BioAssay type | screening | | Target | GALR3 gene product [Homo sapiens] [gi:4503907] | | PubMed | | | Data Table |  |
|
| 42 | [SID124753546] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3) [AID651719, Type: screening] | GALR3 gene product [Homo sapiens] [gi:4503907] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3) | | AID | 651719 | | BioAssay type | screening | | Target | GALR3 gene product [Homo sapiens] [gi:4503907] | | PubMed | | | Data Table |  |
|
| 43 | [SID124753546] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) [AID624267, Type: screening] | RIPK2 gene product [Homo sapiens] [gi:4506537] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) | | AID | 624267 | | BioAssay type | screening | | Target | RIPK2 gene product [Homo sapiens] [gi:4506537] | | PubMed | | | Data Table |  |
|
| 44 | [SID124753546] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) [AID624267, Type: screening] | RIPK2 gene product [Homo sapiens] [gi:4506537] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) | | AID | 624267 | | BioAssay type | screening | | Target | RIPK2 gene product [Homo sapiens] [gi:4506537] | | PubMed | | | Data Table |  |
|
| 45 | [SID124753546] | Inactive | | | uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay [AID624354, Type: screening] | TNFRSF10B gene product [Homo sapiens] [gi:224494019] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Inactive | | BioAssay | uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay | | AID | 624354 | | BioAssay type | screening | | Target | TNFRSF10B gene product [Homo sapiens] [gi:224494019] | | PubMed | | | Data Table |  |
|
| 46 | [SID124753546] | Inactive | | | uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay [AID624354, Type: screening] | TNFRSF10B gene product [Homo sapiens] [gi:224494019] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Inactive | | BioAssay | uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay | | AID | 624354 | | BioAssay type | screening | | Target | TNFRSF10B gene product [Homo sapiens] [gi:224494019] | | PubMed | | | Data Table |  |
|
| 47 | [SID124753546] | Inactive | | | uHTS identification of inhibitors of cullin neddylation in a TR-FRET assay [AID651699, Type: screening] | NAE1 gene product [Homo sapiens] [gi:4502169] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Inactive | | BioAssay | uHTS identification of inhibitors of cullin neddylation in a TR-FRET assay | | AID | 651699 | | BioAssay type | screening | | Target | NAE1 gene product [Homo sapiens] [gi:4502169] | | PubMed | | | Data Table |  |
|
| 48 | [SID124753546] | Inactive | | | uHTS identification of small molecule activators of alpha dystroglycan glycosylation [AID624168, Type: screening] | LARGE [Homo sapiens] [gi:47678551] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule activators of alpha dystroglycan glycosylation | | AID | 624168 | | BioAssay type | screening | | Target | LARGE [Homo sapiens] [gi:47678551] | | PubMed | | | Data Table |  |
|
| 49 | [SID124753546] | Inactive | | | Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) [AID602229, Type: screening] | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) | | AID | 602229 | | BioAssay type | screening | | Target | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] | | PubMed | | | Data Table |  |
|
| 50 | [SID124753546] | Inactive | | | Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) [AID602229, Type: screening] | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 124753546 | | CID | 53299662 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) | | AID | 602229 | | BioAssay type | screening | | Target | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] | | PubMed | | | Data Table |  |
|